OncoMatch/Clinical Trials/Leukemia — Chronic Myeloid (CML)
Leukemia — Chronic Myeloid (CML) Clinical Trials
OncoMatch filters Leukemia — Chronic Myeloid (CML) trials by the molecular markers that determine eligibility — BCR, ABL1, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Leukemia — Chronic Myeloid (CML) trials
These are the molecular markers most commonly required or evaluated in Leukemia — Chronic Myeloid (CML) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Leukemia — Chronic Myeloid (CML) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Study of Olverembatinib (HQP1351) in Patients With CP-CML
Ascentage Pharma Group Inc.
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Il-Yang Pharm. Co., Ltd.
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
Poitiers University Hospital
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Center for International Blood and Marrow Transplant Research
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
Baylor College of Medicine
How OncoMatch finds Leukemia — Chronic Myeloid (CML) trials for you
AI reads the protocol
Every Leukemia — Chronic Myeloid (CML) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Leukemia — Chronic Myeloid (CML) and mark your biomarker results — BCR, ABL1 — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.